Xencor
XNCR
#4331
Rank
โ‚น236.54 B
Marketcap
โ‚น3,152
Share price
0.00%
Change (1 day)
125.90%
Change (1 year)

Earnings for Xencor (XNCR)

Earnings in 2026 (TTM): -โ‚น10.73 Billion

According to Xencor's latest financial reports the company's current earnings are โ‚น0.20 Billion. In 2025 the company made an earning of -โ‚น8.31 Billion, an increase over its 2024 earnings that were of -โ‚น22.53 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Xencor from 2013 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น10.73 Billion29.06%
2025 -โ‚น8.31 Billion-63.11%
2024 -โ‚น22.53 Billion101.73%
2023 -โ‚น11.17 Billion120.95%
2022 -โ‚น5.06 Billion-165.97%
2021 โ‚น7.65 B-219.18%
2020 -โ‚น6.43 Billion-355.02%
2019 โ‚น2.51 B-138.61%
2018 -โ‚น6.53 Billion21.07%
2017 -โ‚น5.4 Billion-336.25%
2016 โ‚น2.28 B-239.93%
2015 -โ‚น1.64 Billion7.12%
2014 -โ‚น1.53 Billion-72.75%
2013 -โ‚น5.59 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚น1.735 T-16,300.24%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
โ‚น1.187 T-11,188.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น1.024 T-9,663.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น623.15 B-5,917.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
-โ‚น73.28 Billion 584.13%๐Ÿ‡บ๐Ÿ‡ธ USA
MacroGenics
MGNX
-โ‚น9.69 Billion-9.55%๐Ÿ‡บ๐Ÿ‡ธ USA